Carcinoma Matrix Interactions Consortium

Skibotn, Tromsø, 22-24 September 2008

Skibotn, Tromsø, 20-22 September 2009

Bjorøy, Bergen, 11-12 May 2010

Coexpression and nuclear colocalization of metastasis-promoting protein S100A4 and p53 without mutual regulation in colorectal carcinoma. Berge G, Costea DE, Berg M, Rasmussen H, Grotterød I, Lothe RA, Mælandsmo GM, Flatmark K. Amino Acids. 2010 Feb 27.

Collagen I regulates matrix metalloproteinase-2 activation in osteosarcoma cells independent of S100A4. Elenjord R, Allen JB, Johansen HT, Kildalsen H, Svineng G, Maelandsmo GM, Loennechen T, Winberg JO. FEBS J. 2009 Sep;276(18):5275-86.

Mælandsmo’s Group, Tumor Biology, Institute of Cancer Research, Oslo

Leader: Prof. Gunhild M. Mælandsmo

Bergen Oral Cancer Group, University of Bergen

Leader: Prof. Anne Christine Johannessen

Tumour Biology Group, University of Tromsø

Leader: Prof. Lars Uhlin-Hansen

Welcome to UiB Blogs. This is your first post. Edit or delete it, then start blogging!

Carcinoma Matrix Interactions Consortium Norway (CARMACO) is a multicenter research collaboration with the primary objective of generating a comprehensive understanding of the mechanisms of epithelial-stroma interactions in human carcinoma.

This research consortium consists of three independent research groups at The Norwegian Radium Hospital in Oslo (DNR), and Universities of Bergen and Tromsø, each of them tackling various, complementary aspects of tumour biology, but forming together a synergic collaboration headed by Prof. Gunhild M. Mælandsmo.

Contact:

Department of Tumor Biology, Institute for Cancer Research
The Norwegian Radium Hospital, Montebello, 0310 Oslo, Norway
Phone: +47 22 78 18 79(Mælandsmo) +47 22 78 12 68(Dept. secretary), Fax: +47 22 78 17 95
Email: gunhildm@rr-research.no